Dietary Polyphenols Alleviate Autoimmune Liver Disease by Mediating the Intestinal Microenvironment: Challenges and Hopes

J Agric Food Chem. 2022 Sep 7;70(35):10708-10737. doi: 10.1021/acs.jafc.2c02654. Epub 2022 Aug 25.

Abstract

Autoimmune liver disease is a chronic liver disease caused by an overactive immune response in the liver that imposes a significant health and economic cost on society. Due to the side effects of existing medicinal medications, there is a trend toward seeking natural bioactive compounds as dietary supplements. Currently, dietary polyphenols have been proven to have the ability to mediate gut-liver immunity and control autoimmune liver disease through modulating the intestinal microenvironment. Based on the preceding, this Review covers the many forms of autoimmune liver illnesses, their pathophysiology, and the modulatory effects of polyphenols on immune disorders. Finally, we focus on how polyphenols interact with the intestinal milieu to improve autoimmune liver disease. In conclusion, we suggest that dietary polyphenols have the potential as gut-targeted modulators for the prevention and treatment of autoimmune liver disease and highlight new perspectives and critical issues for future pharmacological applications.

Keywords: autoimmune liver disease; dietary polyphenols; gut−liver axis; intestinal environment; liver; microbiome.

Publication types

  • Review

MeSH terms

  • Dietary Supplements
  • Gastrointestinal Microbiome*
  • Humans
  • Liver Diseases* / drug therapy
  • Polyphenols / pharmacology

Substances

  • Polyphenols